Rodman David Malcom

Avg. Two Year Performance

No purchase track record
69% Avg. Sale Return
30% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return15%11%49%44%69%
Sale Success Rate1 of 31 of 32 of 32 of 33 of 3
Drugs » Biotechnology

Exec Vice President and CMO:

Holdings: 11.37K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Chief Medical Officer:

Holdings: 67.0K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--